Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for Sample Preservation for Investigation Purpose – V 2.0

Posted on By

API Manufacturing: SOP for Sample Preservation for Investigation Purpose – V 2.0

Standard Operating Procedure for Sample Preservation for Investigation Purpose in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/118/2025
Supersedes SOP/API/118/2022
Page No. Page 1 of 9
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To establish a standard method for preserving samples for quality investigation during API manufacturing in order to ensure traceability, integrity, and compliance with regulatory requirements.

2. Scope

This SOP applies to all in-process, intermediate, or final API samples that are required to be preserved for extended evaluation or root cause investigation due to process deviations, unexpected results, or customer

complaints.

3. Responsibilities

  • QC Analyst: Collect and label investigation samples, record relevant details, and store under specified conditions.
  • QA Officer: Review sample retention entries, verify storage conditions, and authorize release or destruction post-investigation.
  • Production Chemist: Identify and notify potential sample preservation needs during batch processing.
See also  API Manufacturing: SOP for Documentation of In-Process Control Results - V 2.0

4. Accountability

The QA Head is accountable for ensuring proper sample retention practices, documentation, and release/disposal authorization after investigation closure.

5. Procedure

5.1 Sample Collection for Investigation

  1. Samples to be preserved may arise from:
    • Out-of-Specification (OOS) or Out-of-Trend (OOT) observations
    • Processing deviations
    • Customer complaint investigation
    • Visual abnormalities or inconsistent results
  2. QC Analyst or Production shall collect 10–25 g (solid) or 10–25 mL (liquid) samples, depending on investigation type and analytical requirements.

5.2 Labeling Requirements

  1. Each preserved sample shall bear a label clearly mentioning:
    • “Sample for Investigation” (Red label)
    • Batch No. and Sample Type
    • Date of Collection
    • Reason for Preservation (e.g., OOS, Deviation No., Complaint ID)
    • Stored By and Verified By

5.3 Documentation

  1. Record the preserved sample details in the Investigation Sample Logbook (Annexure-1), including:
    • Investigation trigger (Deviation/OOS ID)
    • Storage location and conditions
    • Expected retention duration
  2. Update the status in the deviation/investigation file, and assign QA tracking number.
See also  API Manufacturing: SOP for Stage-Wise Approval of API Manufacturing - V 2.0

5.4 Storage Conditions

  1. Store preserved samples in a dedicated investigation cabinet with restricted access and temperature monitoring (if applicable).
  2. Conditions:
    • Solids: Room temperature (15–25°C) unless otherwise specified
    • Liquids: Cool conditions (2–8°C) if stability is a concern

5.5 Sample Review and Disposal

  1. Upon completion of investigation:
    • QA will assess whether the sample is required for re-analysis or retained further.
    • If no longer required, sample shall be destroyed following SOP/API/106/2025.
  2. Destruction shall be documented in the Investigation Sample Disposal Record (Annexure-2).

6. Abbreviations

  • IPC: In-Process Control
  • OOS: Out of Specification
  • OOT: Out of Trend
  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • QC: Quality Control

7. Documents

  1. Investigation Sample Logbook (Annexure-1)
  2. Investigation Sample Disposal Record (Annexure-2)
  3. Deviation Report / OOS Report
See also  API Manufacturing: SOP for Reporting Deviations in IPC Parameters - V 2.0

8. References

  • ICH Q7 – GMP for Active Pharmaceutical Ingredients
  • 21 CFR Part 211 – US FDA cGMP Guidelines
  • WHO TRS 986 – Annex 2: GMP for APIs

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Investigation Sample Logbook

Date Batch No. Sample Type Reason Stored By Storage Location QA Verified
13/04/2025 API-20250413 Drying Intermediate OOT in LOD Sunita Reddy Cabinet-02 Yes

Annexure-2: Investigation Sample Disposal Record

Date Sample ID Batch No. Disposed By Witnessed By Disposal Method
20/04/2025 INV-2025-004 API-20250413 Ravi Kumar QA Officer Incineration

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Release New SOP QA Head
13/04/2025 2.0 Added Annexures and disposal documentation Audit Recommendation QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Elixir Department: SOP for Use of Water for Injection (WFI) in Elixir Production – V 2.0
Next Post: Creams: SOP for Ensuring Batch-to-Batch Consistency in Cream Manufacturing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version